Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01307267What this trial is testingPF-05082566 As A Single Agent And In Combination With RituximabWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more Pfizer 190
Early research (Phase 1)Active Not RecruitingNCT01590069What this trial is testingAerosolized Aldesleukin in Treating Patients With Lung MetastasesWho this might be right forMetastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more M.D. Anderson Cancer Center 70
Not applicableLooking for participantsNCT06724159What this trial is testingObservational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.Who this might be right forGenitourinary Cancers Spanish Oncology Genito-Urinary Group 500
Not applicableUnknownNCT06424080What this trial is testingOncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.Who this might be right forRenal Cell Carcinoma Menoufia University 20
Early research (Phase 1)Ended earlyNCT00816686What this trial is testingThe Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell CancerWho this might be right forCarcinoma, Renal CellKidney NeoplasmsKidney Diseases Astellas Pharma Inc 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05468697What this trial is testingBelzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 60
Early research (Phase 1)Looking for participantsNCT07128680What this trial is testingImmunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00126503What this trial is testingSorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney CancerWho this might be right forChromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more National Cancer Institute (NCI) 73
Not applicableEnded earlyNCT02747173What this trial is testingAssessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging TechniquesWho this might be right forRenal Cell Carcinoma Spanish Oncology Genito-Urinary Group 4
Testing effectiveness (Phase 2)Study completedNCT00005851What this trial is testingLow-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07175480What this trial is testingPET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate RiskWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC) Jinling Hospital, China 30
Testing effectiveness (Phase 2)Study completedNCT00126490What this trial is testingBevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00004890What this trial is testingBiomed 101 and Interleukin-2 in Treating Patients With Kidney CancerWho this might be right forDrug ExtravasationKidney Cancer BioMedicines
Testing effectiveness (Phase 2)Looking for participantsNCT05319015What this trial is testingNeoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor ThrombusWho this might be right forRenal Cell Carcinoma University of Texas Southwestern Medical Center 30
Not applicableStudy completedNCT02411968What this trial is testingFollow up After Cryoablation of Small Renal Masses.Who this might be right forCarcinoma, Renal Cell Radboud University Medical Center 9
Not applicableStudy completedNCT02370290What this trial is testingQuantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney CancerWho this might be right forRenal Cell Carcinoma University of Southern California 74
Not applicableStudy completedNCT01773655What this trial is testingClinical and Histopathologic Characteristics of BAP1 MutationsWho this might be right forMalignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more Memorial Sloan Kettering Cancer Center 196
Not applicableLooking for participantsNCT05231655What this trial is testingEx VIvo DEtermiNed Cancer TherapyWho this might be right forBladder CancerKidney CancerMelanoma+3 more Sheffield Teaching Hospitals NHS Foundation Trust 600
Testing effectiveness (Phase 2)Looking for participantsNCT05361720What this trial is testingGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more Vanderbilt-Ingram Cancer Center 54